CD8A and head and neck squamous cell carcinoma: We measured the Ca2+ fluxing abilities of CD8+ PBTs from HNSCC patients using a TG-based protocol that allows us to assess Ca2+ fluxes dependent on ion channel activity while bypassing the TCR (Newton et al., 2020).